biosciences

19.04.2023 • News

US Merck Snaps up Prometheus Biosciences for $10.8 Billion

Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion.

14.01.2019 • News

Tosoh Boosts Biosciences with Semba Buy

12.11.2015 • News

DuPont to Buy Dyadic Biotech Assets

24.06.2014 • News

Bayer and Dimension Collaborate on Hemophilia A

04.04.2014 • News

BASF Launches Inorganics-Focused California R&D Center

24.01.2013 • News

Baxter Profit Higher; Sales Seen Rising 10% in 2013

Top-Feature

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

CAS

Pioneering End-to-End Green Chemical Production

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Interview

Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.